This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Epalex Corporation, Mirati Therapeutics, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations and Contributions of Inventor Samuel Andrew
Introduction
Samuel Andrew is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on innovative treatments and compositions that address critical health issues.
Latest Patents
Among his latest patents is the development of fospropofol salts, which are pharmaceutically acceptable salts used to treat migraine. Another significant invention is related to crystalline forms of a KRas G12C inhibitor. This invention includes pharmaceutical compositions and methods for preparing these crystalline forms, showcasing his expertise in medicinal chemistry.
Career Highlights
Samuel Andrew has worked with prominent companies in the pharmaceutical industry, including Epalex Corporation and Mirati Therapeutics, Inc. His career reflects a commitment to advancing medical science through innovative solutions.
Collaborations
Throughout his career, Samuel has collaborated with esteemed colleagues such as Randall B Murphy and Steven L Krill. These partnerships have likely contributed to the success of his inventions and patents.
Conclusion
Samuel Andrew's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile